acetylcysteine has been researched along with ketamine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Welte, T | 1 |
| Li, H; Tian, H; Zhang, G; Zhang, Q | 1 |
| Guo, J; Meng, F; Zhang, G; Zhang, Q | 1 |
| Barton, D; Grothey, A; Kottschade, L; Loprinzi, C; Wolf, S | 1 |
| Chen, SD; Ding, JQ; Hong, Z; Pan, J; Sheng, CY; Wang, G; Xiao, Q; Yang, HQ | 1 |
| D'Souza, DC; Ford, JM; Gueorguieva, R; Gunduz-Bruce, H; Krystal, JH; Mathalon, DH; Oliver, S; Reinhart, RM; Roach, BJ | 1 |
| Berk, M; Bush, AI; Dean, OM | 1 |
| Dumas, M; Gu, Q; Kanungo, J; Robinson, B | 1 |
| Abd El-Rady, NM; Ahmed, AM; El Shehaby, DM; El-Mahdy, RI; Hosny, A | 1 |
3 review(s) available for acetylcysteine and ketamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Drug therapy in acute and chronic respiratory insufficiency].
Topics: Acetylcysteine; Acute Disease; Analgesics; Anti-Bacterial Agents; Bronchodilator Agents; Cholinergic Antagonists; Chronic Disease; Expectorants; Glucocorticoids; Humans; Ketamine; Palliative Care; Respiratory Insufficiency; Sympathomimetics | 2001 |
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
Topics: Acetylcarnitine; Acetylcysteine; Anticonvulsants; Antidepressive Agents, Tricyclic; Antineoplastic Agents; Baclofen; Calcium; Glutamine; Humans; Infusions, Intravenous; Ketamine; Magnesium; Naphthalenes; Nootropic Agents; Paclitaxel; Peripheral Nervous System Diseases; Pyridines; Randomized Controlled Trials as Topic; Vitamin E | 2008 |
1 trial(s) available for acetylcysteine and ketamine
| Article | Year |
|---|---|
Glutamatergic modulation of auditory information processing in the human brain.
Topics: Acetylcysteine; Adult; Behavior; Cognition; Electroencephalography; Event-Related Potentials, P300; Evoked Potentials, Auditory; Excitatory Amino Acid Antagonists; Female; Free Radical Scavengers; Humans; Ketamine; Male; Memory; Psychomotor Performance; Reaction Time; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2012 |
8 other study(ies) available for acetylcysteine and ketamine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antioxidant NAC and AMPA/KA receptor antagonist DNQX inhibited JNK3 activation following global ischemia in rat hippocampus.
Topics: Acetylcysteine; Animals; Brain Ischemia; Calcium Channel Blockers; Excitatory Amino Acid Antagonists; Free Radical Scavengers; Immunoblotting; Ketamine; Male; Mitogen-Activated Protein Kinase 10; Mitogen-Activated Protein Kinases; Nifedipine; Protein Transport; Protein-Tyrosine Kinases; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Time Factors | 2003 |
Free radicals are involved in continuous activation of nonreceptor tyrosine protein kinase c-Src after ischemia/reperfusion in rat hippocampus.
Topics: Acetylcysteine; Animals; Brain Ischemia; CSK Tyrosine-Protein Kinase; Dose-Response Relationship, Drug; Enzyme Activation; Excitatory Amino Acid Antagonists; Free Radical Scavengers; Free Radicals; Hippocampus; Immunoblotting; Ketamine; Male; Phosphopyruvate Hydratase; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Reperfusion; src-Family Kinases; Sulfur Isotopes; Time Factors | 2003 |
Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcysteine; Animals; Blotting, Western; Cell Nucleus; Dopamine; Dopamine Agents; Enzyme Activation; Excitatory Amino Acid Antagonists; Immunohistochemistry; Immunoprecipitation; Ketamine; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 10; Neostriatum; Neurons; Parkinson Disease; Protein Transport; Quinoxalines; Tyrosine 3-Monooxygenase | 2009 |
Translating the Rosetta Stone of N-acetylcysteine.
Topics: Acetylcysteine; Autistic Disorder; Behavior; Event-Related Potentials, P300; Evoked Potentials, Auditory; Excitatory Amino Acid Antagonists; Female; Free Radical Scavengers; Humans; Ketamine; Male | 2012 |
N-acetylcysteine prevents ketamine-induced adverse effects on development, heart rate and monoaminergic neurons in zebrafish.
Topics: Acetylcysteine; Anesthetics, Dissociative; Animals; Biogenic Monoamines; Dose-Response Relationship, Drug; Embryo, Nonmammalian; Embryonic Development; Free Radical Scavengers; Heart Rate; Ketamine; Neurons; Zebrafish | 2018 |
Neurobehavioral, testicular and erectile impairments of chronic ketamine administration: Pathogenesis and ameliorating effect of N-acetyl cysteine.
Topics: Acetylcysteine; Analgesics; Animals; Antioxidants; Behavior, Animal; Cognitive Dysfunction; Erectile Dysfunction; Female; Hippocampus; Ketamine; Luteinizing Hormone; Male; Prefrontal Cortex; Rats; Sperm Count; Sperm Motility; Testis; Testosterone | 2020 |